Severe pulmonary hypertension in histiocytosis X

American Journal of Respiratory and Critical Care Medicine

Volumn 161, Issue 1, 2000, Pages 216-223

  Fartoukh, Muriel ^a   Humbert, Marc ^a   Capron, Frédérique ^a   Maître, Sophie ^a   Parent, Florence ^a   Le Gall, Catherine ^a   Sitbon, Olivier ^a   Hervé, Philippe ^a   Duroux, Pierre ^a   Simonneau, Gérald ^a  

^a HÔPITAL ANTOINE BÉCLÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHRONIC LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; EXERCISE; FEMALE; HEART INDEX; HISTIOCYTOSIS X; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ARTERY PRESSURE; LUNG CIRCULATION; LUNG FIBROSIS; LUNG HEMODYNAMICS; LUNG RESISTANCE; MALE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RESPIRATORY FUNCTION;

EID: 0033968257     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.161.1.9807024     Document Type: Article

References (38)

1. 1. Weitzenblum, E., C. Hirth, J. P. Parini, J. Rasaholinjanahary, and P. Oudet. 1978. Clinical, functional and pulmonary hemodynamic course of patients with chronic obstructive pulmonary disease followed-up over 3 years. Respiration 36:1-9.
2. 2. Weitzenblum, E., A. Loiseau, C. Hirth, R. Mirhom, and J. Rasaholinjanahary. 1979. Course of pulmonary hemodynamics in patients with chronic obstructive pulmonary disease. Chest 75:657-662.
3. 3. Weitzenblum, E., A. Sautegeau, M. Ehrhart, M. Mammosser, C. Hirth, and E. Roegel. 1984. Long-term course of pulmonary arterial pressure in chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 130: 993-998.
4. 4. Alpert, J. S. 1979. Pulmonary hypertension and cardiac function in chronic obstructive pulmonary disease. Chest 75:651-652.
5. 5. Macnee, W. 1994. Pathophysiology of cor pulmonale in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 150:833-852.
6. 6. Crystal, R. G., J. D. Fulmer, W. C. Roberts, M. L. Moss, B. R. Line, and H. Y. Reynolds. 1976. Idiopathic pulmonary fibrosis: clinical histologic, radiographic, physiologic, scintigraphic, cytologic and biochemical aspects. Ann. Intern. Med. 85:769-788.
7. 7. Hance, A. J., J. Cadranel, P. Soler, and F. Basset. 1988. Pulmonary and extrapulmonary Langerhans' cell granulomatosis (histiocytosis X). Semin. Respir. Med. 9:349-368.
8. 8. Basset, F., B. Corrin, H. Spencer, J. Lacronique, C. Roth, P. Soler, J. P. Battesti, R. Georges, and J. Chrétien. 1978. Pulmonary histiocytosis X. Am. Rev. Respir. Dis. 118:811-820.
9. 9. Keogh, B. A., E. Lakatos, D. Price, and R. G. Crystal. 1984. Importance of the lower respiratory tract in oxygen transfer: exercise testing in patients with interstitial and destructive lung disease. Am. Rev. Respir. Dis. 129(2, Pt. 2):S76-S80.
10. 10. Craussman, R. S., C. A. Jennings, R. M. Tuder, L. M. Ackerson, C. G. Irvin, and T. E. King. 1996. Pulmonary histiocytosis X: pulmonary function and exercise pathophysiology. Am. J. Respir. Crit. Care Med. 153:426-435.
11. 11. Friedman, P. J., A. A. Licbow, and J. Sokoloff. 1981. Eosinophilic granuloma of lung. Clinical aspects of primary pulmonary histiocytosis in the adult. Medicine (Baltimore) 60:385-396.
12. 12. Soler, P., M. Kambouchner, D. Valeyre, and A. J. Hance. 1992. Pulmonary Langerhans' cell granulomatosis (histiocytosis X). Annu. Rev. Med. 43:105-115.
13. 13. Travis, W. D., Z. Borok, J. H. Roum, J. Zhang, I. Feuerstein, V. J. Ferrans, and R. G. Crystal. 1993. Pulmonary Langerhans' cell granulomatosis (histiocytosis X). A clinical study of 48 cases. Am. J. Surg. Pathol. 17:971-986.
14. 14. Colby, T. V., and C. Lombard. 1983. Histiocytosis X in the lung. Hum. Pathol. 14:847-856.
15. 15. Harari, S., G. Simonneau, E. De Juli, F. Brenot, J. Cerrina, P. Colombo, E. Gronda, E. Micallef, F. Parent, and P. Dartevelle. 1997. Prognosis value of pulmonary hypertension in patients with chronic interstitial lung disease referred for lung or heart-lung transplantation. J. Heart Lung Transplant. 16:460-163.
16. 16. American Thoracic Society. 1995. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 152:S77-S120.
17. 17. Raghu, G. 1987. Idiopathic pulmonary fibrosis: a rational clinical approach. Chest 92:148-154.
18. 18. Sitbon, O., M. Humbert, J. L. Jagot, O. Taravella, M. Fartoukh, F. Parent, P. Hervé, and G. Simonneau. 1998. Inhaled nitric oxide as a screening agent to safely identify responders to oral calcium-channel blockers in primary pulmonary hypertension. Eur. Respir. J. 12:265-270.
19. 19. Sitbon, O., F. Brenot, A. Denjean, A. Bergeron, F. Parent, R. Azarian, P. Hervé, B. Raffestin, and G. Simonneau. 1995. Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin. Am. J. Respir. Crit. Care Med. 151:384-389.
20. 20. Quanjer, P. H. 1993. Standardized lung function testing. Eur. Respir. J. 6(Suppl. 16):3-102.
21. 21. Schönfeld, N., W. Frank, S. Wenig, P. Uhrmeister, E. Allica, H. Preussler, A. Grassot, and R. Loddenkemper. 1993. Clinical and radiologic features, lung function and therapeutic results in pulmonary histiocytosis X. Respiration 60:38-44.
22. 22. Grenier, P., D. Valeyre, P. Cluzel, M. W. Brauner, S. Lenoir, and C. Chastang. 1991. Chronic diffuse lung disease: diagnosis value of chest radiography and high-resolution CT. Radiology 179:123-132.
23. 23. Kulwiec, E. L., D. A. Lynch, S. M. Aguayo, M. I. Schwarz, and T. E. King. 1992. Imaging of pulmonary histiocytosis X. Radiographics 12: 515-526.
24. 24. Brauner, M. W., P. Grenier, M. M. Mouelhi, D. Monpoint, and S. Lenoir. 1989. Pulmonary histiocytosis X: evaluation with high-resolution CT. Radiology 172:255-258.
25. 25. Brauner, M. W., P. Grenier, K. Tijani, J. P. Battesti, and D. Valeyre. 1997. Pulmonary Langerhans cell histiocytosis: evolution of lesions on CT scans. Radiology 204:497-502.
26. 26. Rich, S., D. R. Dantzker, S. M. Ayres, E. H. Bergofsky, B. H. Brundage, K. M. Detre, A. P. Fishman, R. M. Goldring, B. M. Groves, S. K. Koerner, P. C. Levy, L. M. Reid, C. E. Vreim, and G. W. Williams. 1987. Primary pulmonary hypertension: a national prospective study. Ann. Intern. Med. 107:216-223.
27. 27. Botney, M. D., L. Bahadori, and L. I. Gold. 1994. Vascular remodeling in primary pulmonary hypertension: potential role for transforming growth factor-β. Am. J. Pathol. 144:286-295.
28. 28. Humbert, M., G. Monti, F. Brenot, O. Sitbon, A. Portier, L. Grangeot-Keros, P. Duroux, P. Galanaud, G. Simonneau, and D. Emilie. 1995. Increased interleukin-1 and interleukin-6 serum concentration in severe primary pulmonary hypertension. Am. J. Respir. Crit. Care Med. 151:1628-1631.
29. 29. Humbert, M., G. Monti, M. Fartoukh, A. Magnan, F. Brenot, B. Rain, F. Capron, P. Galanaud, P. Duroux, G. Simonneau, and D. Emilie. 1998. Platelet-derived growth factor expression in primary pulmonary hypertension: comparison of HIV seropositive and HIV seronegative patients. Eur. Respir. J. 11:554-559.
30. 30. Tazi, A., M. Bonay, M. Grandsaigne, J. P. Battesti, A. J. Hance, and P. Soler. 1993. Surface phenotype of Langerhans' cells and lymphocytes in granulomatous lesions from patients with pulmonary histiocytosis X. Am. Rev. Respir. Dis. 147:1531-1536.
31. 31. Asakura, S., T. V. Colby, and A. H. Limper. 1996. Tissue localization of transforming growth factor-β1 in pulmonary eosinophilic granuloma. Am. J. Respir. Crit. Care Med. 154:1525-1530.
32. 32. Sauder, D. N., C. A. Dinarello, and V. B. Morhenn. 1984. Langerhans' cell production of interleukin-1. J. Invest. Dermatol. 82:605-607.
33. 33. Hale, K. A., D. E. Niewoehner, and M. G. Cosio. 1980. Morphologic changes in the muscular pulmonary arteries: relationship to cigarette smoking, airway disease, and emphysema. Am. Rev. Respir. Dis. 122: 273-278.
34. 34. Wilkinson, M., C. A. Langhorne, D. Heath, G. R. Barer, and P. Howard. 1988. A pathophysiological study of 10 cases of hypoxic cor pulmonale. Q. J. Med. 66:65-85.
35. 35. Heath, D. 1996. Remodeling of the pulmonary vasculature in hypoxic lung disease. In A. J. Peacok, editor. Pulmonary Circulation: A Handbook for Clinicians. Chapman & Hall, London. 171-179.
36. 36. Barst, R. J., L. J. Rubin, W. A. Long, M. McGoon, S. Rich, D. Badesch, B. M. Groves, V. F. Tapson, R. C. Bourge, B. H. Brundage, S. K. Koerner, D. Langleben, C. A. Keller, S. Murani, B. F. Uretsky, L. M. Clayton, M. M. Jöbsis, S. D. Blackburn, Jr., D. Shortino, and J. W. Crow. 1996. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N. Engl. J. Med. 334:296-301.
37. 37. Humbert, M., S. Maître, F. Capron, B. Rain, D. Musset, and G. Simonneau. 1998. Pulmonary edema complicating continuous intravenous prostacyclin in pulmonary capillary hemangiomatosis. Am. J. Respir. Crit. Care Med. 157:1681-1685.
38. 38. Rubin, L. J. 1997. Primary pulmonary hypertension. N. Engl. J. Med. 336: 111-117.